Regulatory Approaches to Medical Devices: A Comparison between the United States, European Union, and India
DOI:
https://doi.org/10.32628/IJSRST251378Keywords:
Regulation of medical devices, Classification of devices, Approval before they hit the market, Surveillance after they hit the market, Regulation framework, Food and Drug Administration (U.S. Food and Drug Administration), EU MDR (European Union Medical Device Regulation), a CDSCO (Central Drugs Standard Control Organization)Abstract
Before Medical devices can be marketed, they must undergo a formal process known as marketing authorization. This is a basic regulatory requirement to make sure the devices are safe, effective, and of high quality. It is very important for keeping patients safe, products safe, and making commerce worldwide possible by following global regulations. As the MedTech industry grows around the world, manufacturers need to compare the rules in different areas to come up with effective and legal market strategies. This survey looks at the rules for medical devices in the US, the EU, and India. It focuses on how devices are classified, how they are approved, how they are tested in clinical trials, and how they are watched after they are sold. The U.S. FDA uses a centralized, risk-based approach, while the EU uses a decentralized model with Notified Bodies under the EU MDR 2017/745. This model focuses on clinical data and openness. The Medical Device Rules (2017) govern India's regulatory landscape. It is moving toward being more in line with international standards, but it still has problems with implementation and infrastructure. The Central Drugs Standard Control Organization (CDSCO) first used the CLAA regulatory scheme under the Cosmetics and Drugs Act to make sure that the licensing of some important medications and medical devices in India is the same across the board and is overseen by a central authority. The CLAA (Central Licensing Approval Authority) scheme is unique to India. It gives the Central Drugs Standard Control Organization (CDSCO) the power to issue licenses for higher-risk devices (Class C and D), making sure that there is central oversight. This comparison study finds important differences and points out chances to make regulations more consistent, work more efficiently, and make medical technologies more accessible around the world.
📊 Article Downloads
References
World Health Organization (WHO). Regulation of medical devices: a step-by-step guide [Internet]. 2020 [cited 2025 Jul 23].
Rathi A, Puri A, Deshpande R. Medical Device Regulation Post-COVID-19: Need for Regulatory Agility. J Health Manag. 2021;23(2):206-15. doi: 10.1177/09720634211023899
International Medical Device Regulators Forum (IMDRF). Strategic Plan 2021–2025 [Internet]. 2023 [cited 2025 Jul 23].
U.S. Food and Drug Administration (FDA). Overview of Device Regulation [Internet]. 2020 [cited 2025 Jul 23].
U.S. Food and Drug Administration (FDA). Breakthrough Devices Program [Internet]. 2021 [cited 2025 Jul 23].
Sethi R, Popli H, Sethi S. Medical devices regulation in United States of America, European Union and India: a comparative study. Pharm Regul Aff Open Access. 2017;6(1). DOI: https://doi.org/10.4172/2167-7689.1000179
Am S, Dp M, Da B. Regulatory requirements and drug approval process in India, Europe and US. Int J Drug Regul. 2018;7(2):1-10.
Journal of Pharmaceutical Research International. J Pharm Res Int [Internet]. 2019 Feb 13 [cited 2025 Jul 23].
Gnk G, B N, Vidhya LT. Medical device regulation in US, Europe, China and India. Int J Drug Regul Aff. 2017;5(2):17-25. DOI: https://doi.org/10.22270/ijdra.v5i2.198
Regulatory guidelines for medical devices in India: an overview. Asian J Pharm. 2012 Mar [cited 2025 Jul 23].
Matthew CO, Monica A. E-readiness of Enugu State. Ames Gross, Arthur Chan. India’s latest medical device regulation developments. Pac Bridge Med [Internet]. [cited 2012 Apr 23].
Tarricone R, Banks H, Ciani O, Brouwer W, Drummond MF, Leidl R, et al. An accelerated access pathway for innovative high-risk medical devices under the new European Union medical devices and health technology assessment regulations? Analysis and recommendations. Expert Rev Med Devices. 2023;20(4):259-71. DOI: https://doi.org/10.1080/17434440.2023.2192868
View of regulatory guidelines for medical devices in India: an overview. Asian J Pharm. [cited 2025 Jul 23].
Sorenson C, Drummond M. Improving medical device regulation: the United States and Europe in perspective. Milbank Q. 2014;92(1):114-50. DOI: https://doi.org/10.1111/1468-0009.12043
MacNeill AJ, Hopf H, Khanuja A, Alizamir S, Bilec M, Eckelman MJ, et al. Transforming the medical device industry: road map to a circular economy. Health Aff (Millwood). 2020 Dec 1;39(12):2088-97. DOI: https://doi.org/10.1377/hlthaff.2020.01118
Kaplan AV, Harvey ED, Kuntz RE, Shiran H, Robb JF, Fitzgerald P. Humanitarian use devices/humanitarian device exemptions in cardiovascular medicine. Circulation. 2005 Nov 1;112(18):2883-6. DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.553701
Van Norman GA. Drugs, devices, and the FDA: Part 2. JACC Basic Transl Sci. 2016 Jun 1;1(4):277-87. DOI: https://doi.org/10.1016/j.jacbts.2016.03.009
Maak TG, Wylie JD. Medical device regulation: a comparison of the United States and the European Union. J Am Acad Orthop Surg. 2016 May 18;24(8):537-43. DOI: https://doi.org/10.5435/JAAOS-D-15-00403
Sharma D, Chandra A. Medical device rules - 2017, India: an insight. Appl Clin Res Clin Trials Regul Aff. 2019 Sep 12;7(2):126-34. DOI: https://doi.org/10.2174/2666255813666190912114043
Manita N, Deep A, Vikram N, Rana AC, Sharma PC. Regulation and clinical investigation of medical device in the European Union. Appl Clin Res Clin Trials Regul Aff. 2019 Aug 21;6(3):163-81. DOI: https://doi.org/10.2174/2213476X06666190821095407
Zuckerman DM, Brown P, Nissen SE. Medical device recalls and the FDA approval process. Arch Intern Med. 2011 Feb 15;171(11). DOI: https://doi.org/10.1001/archinternmed.2011.30
Van Norman GA. Drugs, devices, and the FDA: Part 1. JACC Basic Transl Sci. 2016 Apr 1;1(3):170-9. DOI: https://doi.org/10.1016/j.jacbts.2016.03.002
Jarow JP, Baxley JH. Medical devices: US medical device regulation. Urol Oncol. 2014 Nov 6;33(3):128-32. DOI: https://doi.org/10.1016/j.urolonc.2014.10.004
Darrow JJ, Avorn J, Kesselheim AS. FDA regulation and approval of medical devices: 1976–2020. JAMA. 2021 Aug 3;326(5):420. DOI: https://doi.org/10.1001/jama.2021.11171
Makower J, Meer A, Denend L. FDA Impact on U.S. Medical Technology Innovation: A Survey of Over 200 Medical Technology Companies. Stanford University. 2010.
India Brand Equity Foundation (IBEF). Medical Devices Industry Report [Internet]. 2023 [cited 2025 Jul 23].
Fortune Business Insights. Medical Devices Market Size, Share & Industry Analysis [Internet]. 2022 [cited 2025 Jul 23].
Downloads
Published
Issue
Section
License
Copyright (c) 2025 International Journal of Scientific Research in Science and Technology
This work is licensed under a Creative Commons Attribution 4.0 International License.
https://creativecommons.org/licenses/by/4.0
